Coccidioidomycosis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA withdrawal · 2009-08-04
EMA Lapsed: Posaconazole SP (posaconazole) — Schering-Plough Europe
EMA status shows Posaconazole SP has lapsed; therapeutic areas include candidiasis, mycoses, coccidioidomycosis, and aspergillosis.